South America vs Uruguay: Proportion of the target population who received a 3rd dose of
South America
77.0%
in 2024
Uruguay
96.0%
in 2024
South America rank
16th
Uruguay rank
16th
Proportion of the target population who received a 3rd dose of over time
- South America
- Uruguay
How they compare
Uruguay currently reports 96.0% against 77.0% in South America, a difference of 19.0%.
That makes Uruguay's figure about 1.2 times South America's.
Across all 15 years both countries report, Uruguay has been ahead every year.
South America ranks 16th and Uruguay ranks 16th of 37 groups.
Uruguay has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | South America | Uruguay | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 69.8% | 93.4% | 23.6% | Uruguay |
| 2020s | 71.6% | 94.4% | 22.8% | Uruguay |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, South America or Uruguay?
- Uruguay, at 96.0% against 77.0% in South America as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between South America and Uruguay?
- 19.0%, with Uruguay ahead.
- How many years of comparable data are there for South America and Uruguay?
- 15 years are reported by both, from 2010 to 2024.
- How do South America and Uruguay rank globally for proportion of the target population who received a 3rd dose of?
- South America ranks 16th and Uruguay ranks 16th of 37 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.